News
Strategies to enhance virtual care through quality assurance frameworks, technological innovation, and provider support were ...
Two posters will highlight new data from the company’s open-label ASCENT study of LIQ861 (YUTREPIA) in PH-ILD patients with a focus on safety, tolerability, exploratory changes in 6-minute walk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results